Impact of CYP3A5*3 and CYP2C8-HapC on paclitaxel/carboplatin-induced myelosuppression in patients with ovarian cancer. (Q50518000)
Jump to navigation
Jump to search
scientific article published on 23 June 2011
Language | Label | Description | Also known as |
---|---|---|---|
English | Impact of CYP3A5*3 and CYP2C8-HapC on paclitaxel/carboplatin-induced myelosuppression in patients with ovarian cancer. |
scientific article published on 23 June 2011 |
Statements
Impact of CYP3A5*3 and CYP2C8-HapC on paclitaxel/carboplatin-induced myelosuppression in patients with ovarian cancer (English)
Muhammad Suleman Khan
Elisabeth Åvall-Lundqvist